Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery

Steven D. Gore, Albert D. Donnenberg, Barbara A. Zehnbauer, Li Jun Weng, Philip J. Burke

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery'. Together they form a unique fingerprint.

Medicine & Life Sciences